null

Elotuzumab (Anti-CS1) Biosimilar Antibody

SKU:
HDBS0002
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CS1
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Elotuzumab (Anti-CS1) Biosimilar Antibody (HDBS0002)

The Anti-CS1 Elotuzumab Biosimilar (MAB-HDBS0002) is a monoclonal antibody designed for research involving CS1, a cell surface glycoprotein commonly found on multiple myeloma cells. This biosimilar antibody, similar to Elotuzumab, is highly specific and binds to CS1 with high affinity, allowing for the detection and analysis of CS1-expressing cells.CS1, also known as SLAMF7, plays a crucial role in multiple myeloma cell survival and proliferation, making it a promising target for immunotherapy. The Anti-CS1 Elotuzumab Biosimilar offers researchers a valuable tool for studying the mechanisms of action of CS1 and exploring its potential as a therapeutic target in the treatment of multiple myeloma.

With its high specificity and affinity for CS1, this biosimilar antibody is suitable for various research applications, including flow cytometry, immunohistochemistry, and functional assays. Its reliable performance and consistent results make it an essential tool for advancing our understanding of CS1 biology and developing novel treatment strategies for multiple myeloma.